These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2889526)
1. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats. Carr BI Cancer Res; 1987 Nov; 47(21):5577-83. PubMed ID: 2889526 [TBL] [Abstract][Full Text] [Related]
2. Carcinogen-induced drug resistance in rat hepatocytes. Carr BI; Laishes BA Cancer Res; 1981 May; 41(5):1715-9. PubMed ID: 6783299 [TBL] [Abstract][Full Text] [Related]
3. The slow induction of resistant hepatocytes during initiation of hepatocarcinogenesis by the nongenotoxic carcinogen clofibrate. Nagai MK; Farber E Exp Mol Pathol; 1999 Dec; 67(3):144-9. PubMed ID: 10600397 [TBL] [Abstract][Full Text] [Related]
4. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Tsuda H; Lee G; Farber E Cancer Res; 1980 Apr; 40(4):1157-64. PubMed ID: 6101993 [TBL] [Abstract][Full Text] [Related]
5. In vitro measurement of resistance to phalloidin and gamma-glutamyltransferase of carcinogen-induced preneoplastic hepatocytes of rats. Sawada N; Furukawa K; Tsukada H J Natl Cancer Inst; 1982 Sep; 69(3):683-6. PubMed ID: 6125619 [TBL] [Abstract][Full Text] [Related]
6. Production of monoclonal antibodies to preneoplastic liver cell populations induced by chemical carcinogens in rats and to transplantable Morris hepatomas. Dunsford HA; Sell S Cancer Res; 1989 Sep; 49(17):4887-93. PubMed ID: 2474376 [TBL] [Abstract][Full Text] [Related]
7. Resistance to hepatotoxins acquired by hepatocytes during liver regeneration. Roberts E; Ahluwalia MB; Lee G; Chan C; Sarma DS; Farber E Cancer Res; 1983 Jan; 43(1):28-34. PubMed ID: 6401166 [TBL] [Abstract][Full Text] [Related]
8. Sequential analysis of DNA damage and repair during the development of carcinogen-induced rat liver hyperplastic lesions. Brambilla G; Martelli A; Pino A; Robbiano L Cancer Res; 1986 Jul; 46(7):3476-81. PubMed ID: 2871925 [TBL] [Abstract][Full Text] [Related]
9. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Columbano A; Rajalakshmi S; Sarma DS Cancer Res; 1981 Jun; 41(6):2079-83. PubMed ID: 6113048 [TBL] [Abstract][Full Text] [Related]
10. Decreased induction of gamma-glutamyltransferase activity by 3'-methyl-4-dimethylaminoazobenzene in the liver of rats given carcinogen-containing diet for several generations. Higashi T; Fukui R; Sekiyama M; Yoshimoto F; Tateishi N; Sakamoto Y Jpn J Cancer Res; 1986 Feb; 77(2):139-44. PubMed ID: 2870045 [TBL] [Abstract][Full Text] [Related]
11. Cell cycle kinetics of rat hepatocytes in early putative preneoplastic lesions in hepatocarcinogenesis. Rotstein J; Macdonald PD; Rabes HM; Farber E Cancer Res; 1984 Jul; 44(7):2913-7. PubMed ID: 6144384 [TBL] [Abstract][Full Text] [Related]
12. Persistence of resistant putative preneoplastic hepatocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea. Solt DB; Cayama E; Sarma DS; Farber E Cancer Res; 1980 Apr; 40(4):1112-8. PubMed ID: 7357542 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA synthesis by chemical carcinogens in cultures of initiated and normal proliferating rat hepatocytes. Novicki DL; Rosenberg MR; Michalopoulos G Cancer Res; 1985 Jan; 45(1):337-44. PubMed ID: 3965143 [TBL] [Abstract][Full Text] [Related]
14. Immunological approaches to the purification of putative premalignant hepatocytes from genotypic mosaic rat livers. Hunt JM; Buckley MT; Laishes BA; Dunsford HA Cancer Res; 1985 May; 45(5):2226-33. PubMed ID: 2859107 [TBL] [Abstract][Full Text] [Related]
15. Role of acute hepatic necrosis in the induction of early steps in liver carcinogenesis by diethylnitrosamine. Ying TS; Sarma DS; Farber E Cancer Res; 1981 Jun; 41(6):2096-102. PubMed ID: 6113050 [TBL] [Abstract][Full Text] [Related]
16. The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens. Farber E; Parker S; Gruenstein M Cancer Res; 1976 Nov; 36(11 Pt 1):3879-87. PubMed ID: 975037 [TBL] [Abstract][Full Text] [Related]
17. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model. Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317 [TBL] [Abstract][Full Text] [Related]
18. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Solt DB; Medline A; Farber E Am J Pathol; 1977 Sep; 88(3):595-618. PubMed ID: 18937 [TBL] [Abstract][Full Text] [Related]
19. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital. Hanigan MH; Pitot HC Cancer Res; 1985 Dec; 45(12 Pt 1):6063-70. PubMed ID: 3904978 [TBL] [Abstract][Full Text] [Related]
20. Low selection of preneoplastic hepatocytes after treatment with the 2-acetylaminofluorene diet-partial hepatectomy regimen in the liver of hepatocarcinogenesis-resistant DRH strain rats. Imai K; Yamamoto M; Tanaka H; Hashimoto N; Miyakoshi M; Honmou S; Yoshie M; Tamakawa S; Yaginuma Y; Kasai S; Ogawa K Oncol Rep; 2007 Jan; 17(1):55-60. PubMed ID: 17143478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]